Recursion Pharmaceuticals Gross Margin

Gross Margin of Recursion Pharmaceuticals is -61.96 % in 2026.

Gross Margin of Recursion Pharmaceuticals changed from 23.12 % to -61.96 %, representing a -368.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Recursion Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.